|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
Italy HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
|
 |
|
$2300.00 |
| |
|
|
|
Japan HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
|
|
|
$2300.00 |
| |
|
|
|
Spain HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
|
|
|
$2300.00 |
| |
|
|
|
UK HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic and NAT Procedures
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
|
|
|
$2300.00 |
| |
|
|
|
US HIV/AIDS Diagnostics Market: Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs--HIV 1/2, Combo, Ag, NAT, Western Blot----Supplier Shares, Strategies, Country Market Segment Volume and Sales Forecasts for Immunodiagnostic
This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
|
|
|
$2300.00 |
| |
|
|
|
France Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers
This unique report from Venture Planning Group provides France sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2250.00 |
| |
|
|
|
Germany Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers
This unique report from Venture Planning Group provides Germany sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2250.00 |
| |
|
|
|
Italy Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers
This unique report from Venture Planning Group provides Italy sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2250.00 |
| |
|
|
|
Japan Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers
This unique report from Venture Planning Group provides Japan sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2250.00 |
| |
|
|
|
Spain Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers
This unique report from Venture Planning Group provides Spain sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2250.00 |
| |
|
|
|
UK Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers
This unique report from Venture Planning Group provides UK sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2250.00 |
| |
|
|
|
US Sales and Market Shares of Major Clinical Chemistry and Immunodiagnostic Product Suppliers
This unique report from Venture Planning Group provides US sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
|
|
|
$2250.00 |
| |
|
|
|
US Cell Surface Markers: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies....
|
|
|
$2250.00 |
| |
|
|
|
Analysis of the French Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital cancer diagnostics market, including:Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the German Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 533 pages, 40 tables, and presents a comprehensive analysis of the German hospital cancer diagnostics market, including:Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Italian Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital cancer diagnostics market, including:Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Japanese Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including:Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
Analysis of the Spanish Hospital Cancer Diagnostics Market
This new report from Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital cancer diagnostics market, including:Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
|
|
|
$2200.00 |
| |
|
|
|
|